CytoDyn Inc. (CYDY)
↓ Download CSV- Sector Manufacturing
- Incorporated DE
- Fiscal year ends May 31
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0 | $266.0K | $0 | — | — | — | — | — |
| Cost of Revenue | — | — | — | $53.0K | — | — | — | — | — | — |
| Gross Profit | — | — | — | $213.0K | — | — | — | — | — | — |
| Operating Income | $9.66M | -$18.06M | -$40.58M | -$145.40M | -$104.60M | -$74.65M | -$55.85M | -$45.92M | -$27.33M | -$21.18M |
| Net Income | $3.75M | -$49.84M | -$79.82M | -$210.82M | -$176.47M | -$139.94M | -$56.19M | -$50.15M | -$25.76M | -$25.70M |
| EPS (Diluted) | $0.00 | $-0.05 | $-0.10 | $-0.31 | $-0.30 | $-0.33 | — | — | — | — |
| Total Assets | $18.05M | $11.14M | $11.29M | $29.18M | $132.08M | $50.51M | $20.87M | $4.90M | $8.06M | $13.79M |
| Total Liabilities | $114.09M | $127.89M | $120.79M | $123.58M | $153.10M | $52.99M | $29.79M | $18.06M | $9.16M | $3.58M |
| Shareholders' Equity | -$96.04M | -$116.76M | -$109.50M | -$94.40M | -$21.02M | -$2.48M | -$8.91M | -$13.16M | -$1.10M | $10.21M |
| Cash & Equivalents | $11.90M | $3.11M | $2.54M | $4.23M | $33.94M | $14.28M | $2.61M | $1.23M | $1.78M | $9.64M |
| Operating Cash Flow | -$8.77M | -$10.98M | -$25.11M | -$77.72M | -$117.57M | -$68.80M | -$50.47M | -$29.90M | -$26.73M | -$24.81M |
| Capital Expenditures | — | — | — | — | $122.0K | $41.0K | $26.0K | $0 | $11.1K | $11.9K |
| Shares Outstanding | 1.25B | 1.06B | 918.61M | 719.59M | 625.68M | 518.98M | 329.40M | 216.72M | 149.47M | 123.34M |